As noted by a University of Ottawa Professor, Apotex is selling a drug to treat AIDS to Rwanda at a price which is much higher than other available generics from different countries. This brings into question whether Apotex' agreement to provide the drug through Canada's compassionate patent licensing scheme is the best option.

For more information, please see:

http://www.thestar.com/comment/article/244881